Expert Consensus on Vitamin B6 Therapeutic Use for Patients: Guidance on Safe Dosage, Duration and Clinical Management
Drug, Healthcare and Patient Safety · Published 2025-04-01 · DOI 10.2147/dhps.s499941
Free full text
Authors being retrieved — see the publisher record. https://doi.org/10.2147/dhps.s499941
Abstract
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Publication details
- Year
- 2025
Related articles
- Vitamin B6: too much, too little, too late? An analysis of sales trends in Australia from 2023 to 2025 · Internal Medicine Journal · 2026 · Cites or is cited by this article
- Assessing Readability and Usability of Electronic Medicine Package Leaflets in South Korea: A Mixed-Methods Study · Drug, Healthcare and Patient Safety · 2025 · Same journal
- Obstructive Fibrinous Tracheal Pseudomembrane Following Repeated Intratracheal Interventions · Drug, Healthcare and Patient Safety · 2024 · Same journal
- Paracetamol Overdose in Somali Children Under Five: An Emerging Public Health Concern · Drug, Healthcare and Patient Safety · 2025 · Same journal
- Assessment of Knowledge, Attitudes, and Practices on Antibiotic Use and Resistance Among Healthcare Workers in Monrovia, Liberia: A Facility-Based Cross-Sectional Study · Drug, Healthcare and Patient Safety · 2025 · Same journal
- Prevalence of Missed Medication Doses and Outcomes of Hospitalized Patients Living with HIV in Uganda · Drug, Healthcare and Patient Safety · 2026 · Same journal
- Establishing of a National Diagnostic Reference Level for Radiation Dose in Digital Paediatric Pelvic X-Rays in Jordan: A Multicenter Retrospective Study · Drug, Healthcare and Patient Safety · 2025 · Same journal
- The Prevalence and Severity of Potential Drug–Drug Interactions in Internal Medicine Ward at Soba Teaching Hospital · Drug, Healthcare and Patient Safety · 2023 · Same journal
- Response to Osilodrostat Therapy in Adrenal Cushing’s Syndrome · Drug, Healthcare and Patient Safety · 2024 · Same journal
- Cumulative Clinical Experience of the Use of Paliperidone Palmitate 3-Monthly Long-Acting Injection in the Treatment of Schizophrenia: A Critical Appraisal · Drug, Healthcare and Patient Safety · 2023 · Same journal